Results of new-generation balloon vs. self-expandable transcatheter heart valves for bicuspid aortic valve stenosis.
TAVR - transcatheter aortic valve replacement
balloon-expandable valve
bicuspid aortic valve (BAV)
retrospective cohort study
self-expandable valve
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
07
2023
accepted:
17
08
2023
medline:
20
9
2023
pubmed:
20
9
2023
entrez:
20
9
2023
Statut:
epublish
Résumé
Data comparing new-generation self-expandable (SEV, Evolut R/PRO) vs. balloon-expandable (BEV, SAPIEN 3/3Ultra) transcatheter heart valve replacement (TAVR) in bicuspid aortic valve stenosis (BAV) is limited. Our aim was to compare 30-day results of SEV and BEV implantations in patients with BAV. A total of 2009 patients underwent TAVR between April 2015 and June 2021 at our Centre. From our institutional registry, we identified 106 consecutive patients with BAV who underwent TAVR using SEV and BEV. A 106 patients ( Treatment of BAV revealed similar performance using BEV and SEV. In this retrospective cohort study, hemodynamics were more favorable with the SEV, although there was a trend toward more PVL and significantly more post-dilations.
Sections du résumé
Background
UNASSIGNED
Data comparing new-generation self-expandable (SEV, Evolut R/PRO) vs. balloon-expandable (BEV, SAPIEN 3/3Ultra) transcatheter heart valve replacement (TAVR) in bicuspid aortic valve stenosis (BAV) is limited. Our aim was to compare 30-day results of SEV and BEV implantations in patients with BAV.
Methods
UNASSIGNED
A total of 2009 patients underwent TAVR between April 2015 and June 2021 at our Centre. From our institutional registry, we identified 106 consecutive patients with BAV who underwent TAVR using SEV and BEV.
Results
UNASSIGNED
A 106 patients (
Conclusions
UNASSIGNED
Treatment of BAV revealed similar performance using BEV and SEV. In this retrospective cohort study, hemodynamics were more favorable with the SEV, although there was a trend toward more PVL and significantly more post-dilations.
Identifiants
pubmed: 37727303
doi: 10.3389/fcvm.2023.1252163
pmc: PMC10505722
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1252163Informations de copyright
© 2023 Deutsch, Vitanova, Ruge, Erlebach, Krane and Lange.
Déclaration de conflit d'intérêts
KV reports having received lecture honoraria from Medtronic, consulting fees from Medtronic and Astra Zeneca, and support for attending meetings from Edwards Lifesciences. HR reports having received grants or contracts Edwards and payment or honoraria for lectures EdwardsLifesciences. ME reports having received payment or honoraria for lectures Medtronic and Abbott, and consultancy and lecture honoraria from Abbott, and support for attending meetings from Medtronic. RL reports having received royalties or licenses from Medtronic, consulting fees from Medtronic, and stock or stock options from Highlife. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Am Coll Cardiol. 2010 Jun 22;55(25):2789-800
pubmed: 20579534
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1406-1415.e3
pubmed: 30482527
J Am Coll Cardiol. 2012 Oct 9;60(15):1438-54
pubmed: 23036636
Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1408-1418
pubmed: 29315371
Int J Cardiol. 2018 Jul 15;263:171-176
pubmed: 29754916
Am J Cardiol. 2014 Apr 15;113(8):1390-3
pubmed: 24581922
JACC Cardiovasc Interv. 2020 Aug 10;13(15):1749-1759
pubmed: 32473890
J Am Coll Cardiol. 2002 Jun 19;39(12):1890-900
pubmed: 12084585
Mayo Clin Proc. 1999 Jan;74(1):14-26
pubmed: 9987528
Clin Res Cardiol. 2021 Dec;110(12):1993-2006
pubmed: 34505192
Eur Heart J. 1988 Apr;9 Suppl E:57-64
pubmed: 3042404
J Am Coll Cardiol. 2014 Dec 9;64(22):2330-9
pubmed: 25465419
Circ Cardiovasc Interv. 2019 Jan;12(1):e007107
pubmed: 30626202
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
JACC Cardiovasc Interv. 2016 Apr 25;9(8):817-824
pubmed: 27101906
J Heart Valve Dis. 2015 Jan;24(1):10-21
pubmed: 26182615
JAMA. 2019 Jun 11;321(22):2193-2202
pubmed: 31184741
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Circulation. 2005 Feb 22;111(7):920-5
pubmed: 15710758
J Am Coll Cardiol. 2021 Jun 1;77(21):2717-2746
pubmed: 33888385
Cardiol Ther. 2021 Dec;10(2):277-288
pubmed: 34081277
JAMA Cardiol. 2021 Jan 1;6(1):50-57
pubmed: 33031491
Circ Cardiovasc Interv. 2020 Jul;13(7):e008714
pubmed: 32646304
J Am Soc Echocardiogr. 2019 Apr;32(4):431-475
pubmed: 30797660
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
Catheter Cardiovasc Interv. 2015 Aug;86(2):E88-98
pubmed: 25914355
J Am Coll Cardiol. 1990 Apr;15(5):1104-8
pubmed: 2312966
JACC Cardiovasc Imaging. 2016 Oct;9(10):1145-1158
pubmed: 27372022
J Thorac Cardiovasc Surg. 2007 May;133(5):1226-33
pubmed: 17467434
EuroIntervention. 2018 Dec 20;14(12):e1269-e1275
pubmed: 30375336
J Invasive Cardiol. 2015 Mar;27(3):172-80
pubmed: 25740972
Heart Surg Forum. 2016 Feb 24;19(1):E36-42
pubmed: 26913684
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):E746-E757
pubmed: 33555107
Catheter Cardiovasc Interv. 2015 Aug;86(2):323-30
pubmed: 25594190
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
JACC Cardiovasc Imaging. 2015 Mar;8(3):361-370
pubmed: 25772839
J Am Coll Cardiol. 2020 Sep 1;76(9):1018-1030
pubmed: 32854836